QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena (Ospemifene) Phase 3...

drugs.com     May 22, 2008            

Results presented at 12th World Congress on the Menopause show significant improvement in vaginal dryness and dyspareunia, two of the most frequent symptoms associated with vulvovaginal atrophy ANN ARBOR, Mich., May 21, 2008 /PRNewswire/ --... ... Results presented at... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies